###begin article-title 0
Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 631 636 <span type="species:ncbi:9606">human</span>
###xml 638 648 <span type="species:ncbi:9598">chimpanzee</span>
###xml 650 663 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 665 671 <span type="species:ncbi:9913">bovine</span>
###xml 673 676 <span type="species:ncbi:9823">pig</span>
###xml 678 681 <span type="species:ncbi:10116">rat</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 717 722 <span type="species:ncbi:9796">horse</span>
###xml 724 727 <span type="species:ncbi:9685">cat</span>
###xml 729 734 <span type="species:ncbi:9940">sheep</span>
###xml 739 742 <span type="species:ncbi:9615">dog</span>
###xml 792 797 <span type="species:ncbi:9606">human</span>
P-selectin glycoprotein ligand-1 (PSGL-1) plays a critical role in recruiting leukocytes in inflammatory lesions by mediating leukocyte rolling on selectins. Core-2 O-glycosylation of a N-terminal threonine and sulfation of at least one tyrosine residue of PSGL-1 are required for L- and P-selectin binding. Little information is available on the intra- and inter-species evolution of PSGL-1 primary structure. In addition, the evolutionary conservation of selectin binding site on PSGL-1 has not been previously examined in detail. Therefore, we performed multiple sequence alignment of PSGL-1 amino acid sequences of 14 mammals (human, chimpanzee, rhesus monkey, bovine, pig, rat, tree-shrew, bushbaby, mouse, bat, horse, cat, sheep and dog) and examined mammalian PSGL-1 interactions with human selectins.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 990 991 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 228 233 <span type="species:ncbi:9796">horse</span>
###xml 238 241 <span type="species:ncbi:9615">dog</span>
###xml 498 503 <span type="species:ncbi:9606">human</span>
###xml 1035 1040 <span type="species:ncbi:9606">human</span>
###xml 1066 1071 <span type="species:ncbi:9606">human</span>
###xml 1073 1079 <span type="species:ncbi:9913">bovine</span>
###xml 1081 1084 <span type="species:ncbi:9823">pig</span>
###xml 1088 1091 <span type="species:ncbi:10116">rat</span>
###xml 1121 1126 <span type="species:ncbi:9606">human</span>
###xml 1158 1161 <span type="species:ncbi:9823">pig</span>
###xml 1165 1168 <span type="species:ncbi:10116">rat</span>
###xml 1223 1228 <span type="species:ncbi:9606">human</span>
###xml 1232 1238 <span type="species:ncbi:9913">bovine</span>
###xml 1254 1259 <span type="species:ncbi:9606">human</span>
###xml 1271 1276 <span type="species:ncbi:9796">Horse</span>
###xml 1301 1306 <span type="species:ncbi:9606">human</span>
###xml 1310 1316 <span type="species:ncbi:9796">equine</span>
A signal peptide was predicted in each sequence and a propeptide cleavage site was found in 9/14 species. PSGL-1 N-terminus is poorly conserved. However, each species exhibits at least one tyrosine sulfation site and, except in horse and dog, a T [D/E]PP [D/E] motif associated to the core-2 O-glycosylation of a N-terminal threonine. A mucin-like domain of 250-280 amino acids long was disclosed in all studied species. It lies between the conserved N-terminal O-glycosylated threonine (Thr-57 in human) and the transmembrane domain, and contains a central region exhibiting a variable number of decameric repeats (DR). Interspecies and intraspecies polymorphisms were observed. Transmembrane and cytoplasmic domain sequences are well conserved. The moesin binding residues that serve as adaptor between PSGL-1 and Syk, and are involved in regulating PSGL-1-dependent rolling on P-selectin are perfectly conserved in all analyzed mammalian sequences. Despite a poor conservation of PSGL-1 N-terminal sequence, CHO cells co-expressing human glycosyltransferases and human, bovine, pig or rat PSGL-1 efficiently rolled on human L- or P-selectin. By contrast, pig or rat neutrophils were much less efficiently recruited than human or bovine neutrophils on human selectins. Horse PSGL-1, glycosylated by human or equine glycosyltransferases, did not interact with P-selectin. In all five species, tyrosine sulfation of PSGL-1 was required for selectin binding.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
These observations show that PSGL-1 amino acid sequence of the transmembrane and cytoplasmic domains are well conserved and that, despite a poor conservation of PSGL-1 N-terminus, L- and P-selectin binding sites are evolutionary conserved. Functional assays reveal a critical role for post-translational modifications in regulating mammalian PSGL-1 interactions with selectins.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 843 845 843 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Leukocyte recruitment in inflammatory lesions is dependent on the sequential interactions of adhesion receptors with their ligands [1-3]. Leukocyte rolling along inflamed blood vessels is mediated by selectins [4-6]. L-selectin is expressed by leukocytes while activated endothelium and/or platelets express E- or P-selectin [5]. Early in inflammatory reactions [2,3], P-selectin mediates leukocyte rolling on its major ligand P-selectin glycoprotein ligand-1 (PSGL-1) [7]. PSGL-1 is a homodimeric mucin-like glycoprotein [8,9], which is expressed on leukocyte microvilli and functions as a common ligand for the three selectins [10,11]. PSGL-1 interactions with L-selectin strongly amplify leukocyte recruitment by supporting free-flowing leukocyte rolling on leukocytes adherent to microvascular endothelium or leukocyte membrane fragments [11,12]. Moreover, E-selectin interactions with PSGL-1 and CD44 and/or other potential ligands support leukocyte slow rolling along inflamed endothelium [13-15].
###end p 9
###begin p 10
###xml 19 20 19 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x</sup>
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 313 319 <span type="species:ncbi:10090">Murine</span>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 466 472 <span type="species:ncbi:10090">murine</span>
Fucosylated core-2 O-glycans, bearing sialyl Lewis-x (sLex) and/or Lex determinants, attached to human PSGL-1 Thr-57 are required for optimal binding of all three selectins [16-19]. Sulfation of Tyr-46, -48 and -51 is necessary for optimal binding of L- and P-selectin to PSGL-1 but not E-selectin [16-18,20-22]. Murine and human PSGL-1 may differ in their interactions with P-selectin, as sulfation of a single tyrosine residue is sufficient for optimal binding of murine PSGL-1 to P-selectin [23].
###end p 10
###begin p 11
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 396 397 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 928 929 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 951 952 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 14 17 <span type="species:ncbi:10116">rat</span>
###xml 19 25 <span type="species:ncbi:9913">bovine</span>
###xml 30 36 <span type="species:ncbi:9796">equine</span>
###xml 94 100 <span type="species:ncbi:9913">bovine</span>
###xml 105 111 <span type="species:ncbi:9796">equine</span>
###xml 997 1002 <span type="species:ncbi:9606">human</span>
Human, mouse, rat, bovine and equine PSGL-1 sequences encode a signal peptide and, except for bovine and equine PSGL-1, a propeptide, which is predicted to be cleaved by paired basic amino acid converting enzymes (PACE) [9,24-26]. These sequences encode a common PSGL-1 primary structure with a N-terminal peptide expressing potentially sulfated tyrosine residues and a O-glycosylated threonine [9,24,25], and a mucin-like domain constituted of a variable number of decameric repeats (DR) [24-26]. Comparison of these mammal sequences shows that the transmembrane and cytoplasmic domains are highly conserved [9,27,28]. Little information is however available on the intra- and inter-species evolution of decameric motives and on the conservation of PSGL-1 N-terminus. Multiple sequence alignment of a large number of mammalian PSGL-1 sequences is necessary to examine these points and define motives associated with the core-2 O-glycosylation of the N-terminal threonine, homologous to Thr-57 on human PSGL-1.
###end p 11
###begin p 12
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 521 526 <span type="species:ncbi:9606">human</span>
###xml 714 719 <span type="species:ncbi:9606">human</span>
Whether the selectin binding site on mammalian PSGL-1 is evolutionary conserved has not been studied in detail. As PSGL-1 is an attractive target for anti-inflammatory therapy [7,29-39], this information might be helpful to design inhibitors of inflammatory and/or thrombotic reactions [40-42]. We therefore compared PSGL-1 sequences of 14 mammals (9 sequences described herein by us and 5 reported by others; [9,24-26] and performed flow adhesion assays using neutrophils or CHO cells expressing mammalian homologues of human PSGL-1. Despite a poor conservation of the N-terminal amino-acid sequences, we show that L- and P-selectin binding sites are evolutionary conserved and that most mammalian PSGL-1 bind to human selectins. Importantly, these interactions are strongly dependent on PSGL-1 glycosylation and sulfation.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Conservation of PSGL-1 sequence
###end title 14
###begin p 15
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 170 176 <span type="species:ncbi:9796">Equine</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 420 439 <span type="species:ncbi:37347">northern tree shrew</span>
###xml 513 519 <span type="species:ncbi:9913">bovine</span>
###xml 521 526 <span type="species:ncbi:9940">sheep</span>
###xml 528 531 <span type="species:ncbi:9685">cat</span>
###xml 541 547 <span type="species:ncbi:9796">equine</span>
Multiple alignment of mammalian PSGL-1 sequences is presented in figure 1. A signal peptide (SP) cleavage site is predicted between residues 17 and 18 in most sequences. Equine PSGL-1 is an exception with a predicted cleavage site between residues 18 and 19. Nine sequences including human have a propeptide predicted to be cleaved by paired basic amino acid-converting enzymes (PACE/furin; [9,43] at residue 41 (38 for northern tree shrew). By contrast, the PACE consensus sequence, RX [R/K]R is not observed in bovine, sheep, cat, bat and equine PSGL-1 (Fig. 1).
###end p 15
###begin p 16
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Amino acid sequences of mammalian PSGL-1</bold>
###xml 42 46 42 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 112 116 112 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 173 176 <span type="species:ncbi:9685">cat</span>
###xml 181 186 <span type="species:ncbi:9940">sheep</span>
###xml 591 596 <span type="species:ncbi:9606">human</span>
Amino acid sequences of mammalian PSGL-1. (A) Multiple alignment of 12 complete PSGL-1 amino acid sequences and (B) of N-terminal sequences from putative PSGL-1 proteins of cat and sheep, which were inferred respectively from partial genomic sequence and EST sequences identified through homology searches (EMBL/Genbank/DDBJ respective accession numbers: AANG01098304 and DY506895). The putative signal peptide (SP) and propeptide (Pro) cleavage sites are indicated by arrows. The consensus sequence for propeptide cleavage (RX [R/K]R), recognized by PACE, is boxed. Threonine homologous to human Thr-57 is indicated by a black arrowhead. Arbitrary gaps have been added in each sequence in order to isolate and align separately the mucin-like region containing the decameric repeats, which is surrounded by a frame. The transmembrane domain (TM) is marked by a bar. Asterisks indicate the amino acids involved in moesin binding.
###end p 16
###begin p 17
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:10090">mouse</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
N-terminal tyrosine sulfate residues and threonine O-linked glycans are high affinity binding sites for P- and L-selectin to human and mouse PSGL-1 [16-18,20,44-46], which contribute to stabilize leukocyte rolling [16]. A threonine residue, homologous to human PSGL-1 Thr-57, is present in the various species studied here (Fig. 1). Thr-57 belongs to the consensus sequence T [D/E]PP [D/E] in 12 out of 14 species. The region preceding the conserved threonine contains 1 to 3 potentially sulfated tyrosine residues in an acid-rich region (5 species contain 3 tyrosines, 6 contain 2, and 3 only 1; Fig. 1).
###end p 17
###begin p 18
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 801 802 801 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1046 1047 1046 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1061 1063 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 752 755 <span type="species:ncbi:9823">pig</span>
###xml 765 775 <span type="species:ncbi:9598">chimpanzee</span>
###xml 780 793 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
###xml 904 907 <span type="species:ncbi:10116">rat</span>
A mucin-like domain is present in all studied species. It lies between the conserved N-terminal O-glycosylated threonine (Thr-57 in human) and the transmembrane domain, and contains a central region exhibiting decameric repeats (DR). This region was analyzed using the MEME program, whose parameters were applied to each sequence individually and/or simultaneously to all sequences. DR-containing central regions were aligned considering the intra- and inter-species evolution of decameric motives. The degree of inter-species conservation in the N- and C-terminal ends of the mucin-like domain (which sometimes contains traces of mutated decamers) is low. The mucin-like domain is composed of 247 to 322 residues and the number of DR varies from 7 in pig to 18 in chimpanzee and rhesus monkey (Table 2). The number of DR varies in human from 14 to 16 repeats [47-50]. We also observed a polymorphism in rat. One of the three available sequences contains 12 DR [51], whereas only 11 repeats have been observed in the sequences cloned by us (Fig. 1) and others [25]. This polymorphism suggests a dynamic intraspecies evolution of this region.
###end p 18
###begin p 19
Length of the mucin-like domain from the conserved threonine up to the juxta-membrane cysteine
###end p 19
###begin p 20
aa, amino acid
###end p 20
###begin p 21
The analysis of the sequences of PSGL-1 mucin-like regions showed that several constitutive repeats of 10 amino acids can be identified in the center of these regions, while both ends are made up with unconserved amino acids. The best permutation motif, which is the most consistent with the different sequences and which optimizes the number of repeated units per sequence, is AATEAQTTQP.
###end p 21
###begin p 22
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 465 468 <span type="species:ncbi:9615">dog</span>
###xml 597 603 <span type="species:ncbi:9796">equine</span>
Interestingly, in canine PSGL-1, 3 DR strongly differ in their sequences from the others (Fig. 1A). These units are identical to each other and are located every 30 positions. Combining decamera to form repeats of 30 amino acids displays a greater consensus between repeats suggesting that duplication of 30 amino acid units (itself created by two duplications of 10 amino acid units followed by mutations in the third one) arose at least twice in the evolution of dog PSGL-1. The same kind of phenomenon is observed in bat, where the best repeated unit has a length of 15 amino acids. Similarly, equine repeated units exhibit a greater consensus when they are formed of 20 residues units instead of 10 [52].
###end p 22
###begin p 23
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 853 854 853 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 812 817 <span type="species:ncbi:9606">human</span>
A transmembrane domain of 23 residues is predicted in all sequences immediately after the conserved cysteine involved in PSGL-1 dimerization (Fig. 1A). A short extracellular juxta-membrane region is involved in binding versican G3 domain, whose interaction with PSGL-1 promotes leukocyte aggregation [53]. Interestingly, three positions in this region are perfectly conserved in all studied species (Asp-313, Val-317, Lys-318). The transmembrane domain is followed by a cytoplasmic tail, which is made up of two highly conserved regions. Over the 31 first positions of the cytoplasmic domain, 20 are completely conserved and 5 contain conservative substitutions (Fig. 1A). Among the conserved positions, Ser-346, Arg-347, Lys-348 and Ser-358 (Fig. 1A) are involved in moesin binding to the cytoplasmic domain of human PSGL-1 [54]. In all sequences, the C-terminal region is ended by 11 almost perfectly conserved residues.
###end p 23
###begin title 24
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
###xml 50 56 <span type="species:ncbi:9913">bovine</span>
###xml 58 61 <span type="species:ncbi:9823">pig</span>
###xml 65 71 <span type="species:ncbi:9796">equine</span>
Human L- and P-selectin interact with human, rat, bovine, pig or equine CHO-PSGL-1 cells
###end title 24
###begin p 25
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 712 714 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 755 756 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 62 68 <span type="species:ncbi:9913">bovine</span>
###xml 70 73 <span type="species:ncbi:9823">pig</span>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
###xml 82 88 <span type="species:ncbi:9796">equine</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 349 355 <span type="species:ncbi:9913">bovine</span>
###xml 357 360 <span type="species:ncbi:9823">pig</span>
###xml 362 365 <span type="species:ncbi:10116">rat</span>
###xml 369 375 <span type="species:ncbi:9796">equine</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
###xml 554 559 <span type="species:ncbi:9606">human</span>
###xml 561 567 <span type="species:ncbi:9913">bovine</span>
###xml 569 572 <span type="species:ncbi:9823">pig</span>
###xml 574 577 <span type="species:ncbi:10116">rat</span>
###xml 581 587 <span type="species:ncbi:9796">equine</span>
###xml 652 657 <span type="species:ncbi:10090">mouse</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
CHO cells co-expressing human FucT-VII and C2GnT-I and human, bovine, pig, rat or equine PSGL-1 were prepared. The five transfectants expressed similar levels of sLex and CLA. PSGL-1 expression was detected using a mAb reacting with PSGL-1 C-terminal 6 x His tag (Invitrogen). The anti-human PSGL-1 mAbs PL1, KPL1 and PL2 [28,55] did not react with bovine, pig, rat or equine PSGL-1 (data not shown). Flow cytometric analysis of human P- or L-selectin/mu binding to the various CHO-PSGL-1 transfectants showed that P- and L-selectin/mu bind similarly to human, bovine, pig, rat or equine PSGL-1 expressed by transfected CHO cells. As the reactivity of mouse PSGL-1 with human selectins was previously described [23], we did not repeat these analyses (Fig 2).
###end p 25
###begin p 26
###xml 0 103 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human L- and P-selectin/&#956; chimera cross-react with CHO cells expressing mammalian homologues of PSGL-1</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 191 197 <span type="species:ncbi:9913">bovine</span>
###xml 203 206 <span type="species:ncbi:9823">pig</span>
###xml 212 215 <span type="species:ncbi:10116">rat</span>
###xml 223 229 <span type="species:ncbi:9796">equine</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:9606">Human</span>
Human L- and P-selectin/mu chimera cross-react with CHO cells expressing mammalian homologues of PSGL-1. CHO cells, stably expressing similar levels of human C2GnT-I, FucT-VII and human (h), bovine (b), pig (p), rat (r) or equine (e) PSGL-1, were incubated with saturating concentrations of human P- or L-selectin/mu chimeras (filled histogram). Chimera binding was abrogated by 10 mM EDTA (open histogram). Human P- and L-selectin chimera did not bind (< 2%) to mock-transfected CHO cells (not shown). The percentage of positive cells and the mean fluorescence intensity are indicated in each histogram. Histograms are representative of 3-4 experiments.
###end p 26
###begin title 27
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 59 65 <span type="species:ncbi:9913">bovine</span>
###xml 67 70 <span type="species:ncbi:9823">pig</span>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Human L-, P- and E-selectin bind heterogeneously to human, bovine, pig or rat neutrophils
###end title 27
###begin p 28
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 651 653 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 992 994 981 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 1418 1420 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 205 210 <span type="species:ncbi:9606">human</span>
###xml 421 426 <span type="species:ncbi:9606">human</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 535 541 <span type="species:ncbi:9913">bovine</span>
###xml 592 595 <span type="species:ncbi:9823">pig</span>
###xml 600 603 <span type="species:ncbi:10116">rat</span>
###xml 743 748 <span type="species:ncbi:9606">human</span>
###xml 788 794 <span type="species:ncbi:9796">equine</span>
###xml 844 849 <span type="species:ncbi:9606">human</span>
###xml 889 895 <span type="species:ncbi:9796">equine</span>
###xml 1023 1029 <span type="species:ncbi:9913">bovine</span>
###xml 1031 1034 <span type="species:ncbi:9823">pig</span>
###xml 1039 1042 <span type="species:ncbi:10116">rat</span>
###xml 1237 1243 <span type="species:ncbi:9913">bovine</span>
###xml 1245 1248 <span type="species:ncbi:9823">pig</span>
###xml 1250 1253 <span type="species:ncbi:10116">rat</span>
###xml 1258 1264 <span type="species:ncbi:9796">equine</span>
###xml 1400 1405 <span type="species:ncbi:10090">mouse</span>
###xml 1560 1565 <span type="species:ncbi:9606">human</span>
###xml 1661 1667 <span type="species:ncbi:9796">equine</span>
###xml 1694 1699 <span type="species:ncbi:9606">human</span>
###xml 1704 1710 <span type="species:ncbi:9796">equine</span>
###xml 1791 1796 <span type="species:ncbi:10090">mouse</span>
###xml 1798 1801 <span type="species:ncbi:10116">rat</span>
###xml 1803 1806 <span type="species:ncbi:9823">pig</span>
###xml 1810 1816 <span type="species:ncbi:9913">bovine</span>
PSGL-1 expressed by CHO transfectants differ in their glycosylation pattern from mammalian neutrophil PSGL-1. In CHO transfectants, the various mammalian PSGL-1 are glycosylated by FucT-VII and C2GnT-I of human origin, while in mammalian neutrophils PSGL-1 is glycosylated by their own glycosyltransferases. As the glycosylation pattern may affect PSGL-1 interactions with L- or P-selectin, we examined the reactivity of human selectins with mammalian neutrophils (Fig. 3). L- and P-selectin/mu chimera strongly reacted with human and bovine PSGL-1, while a weaker reaction was observed with pig and rat. The L- and P-selectin carbohydrate ligands sLex and CLA, identified by CSLEX-1 and HECA-452 mAbs respectively, were strongly expressed by human neutrophils and also, surprisingly, by equine neutrophils (mean fluorescence intensity +/- SD: human: 74 +/- 1, n = 2 and 79 +/- 12, n = 2; equine: 173 +/- 9, n = 2 and 108 +/- 34, n = 2). By contrast, despite significant selectin binding, sLex and CLA were undetectable on bovine, pig and rat neutrophils (not illustrated). As selectin binding is dependent on cell surface expression of fucosylated ligands, we examined FucT-VII mRNA expression by RT-PCR amplification of total RNA from bovine, pig, rat and equine neutrophils. FucT-VII mRNA transcripts were detected in all investigated species (data not shown). Thus, as previously established for mouse leukocytes [56], the lack of reactivity of mAbs CSLEX-1 and HECA-452 with most mammalian PSGL-1 is likely due to the strong specificity of these mAbs for human oligosaccharides. Moreover, the observation that mAbs CSLEX-1 and HECA-452 strongly react with equine neutrophils suggests that human and equine neutrophils exhibit common carbohydrate structures, which are not detectable in mouse, rat, pig or bovine.
###end p 28
###begin p 29
###xml 0 84 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Human L-, P- or E-selectin/&#956; chimeras bind to human, bovine, pig or rat neutrophils</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 54 60 <span type="species:ncbi:9913">bovine</span>
###xml 62 65 <span type="species:ncbi:9823">pig</span>
###xml 69 72 <span type="species:ncbi:10116">rat</span>
###xml 147 152 <span type="species:ncbi:9606">human</span>
Human L-, P- or E-selectin/mu chimeras bind to human, bovine, pig or rat neutrophils. Neutrophils were incubated with saturating concentrations of human L-, P- or E-selectin/mu chimera (filled histogram). Chimera binding was abrogated by 10 mM EDTA (open histogram). The percentage of positive cells and the mean fluorescence intensity are indicated in each histogram. Histograms are representative of 2-3 experiments.
###end p 29
###begin title 30
###xml 58 63 <span type="species:ncbi:9606">human</span>
CHO cells expressing mammalian PSGL-1 efficiently roll on human L- or P-selectin
###end title 30
###begin p 31
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 132 137 <span type="species:ncbi:9606">Human</span>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 228 234 <span type="species:ncbi:9913">bovine</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 377 383 <span type="species:ncbi:9913">bovine</span>
###xml 385 388 <span type="species:ncbi:9823">pig</span>
###xml 392 395 <span type="species:ncbi:10116">rat</span>
###xml 449 455 <span type="species:ncbi:9796">equine</span>
The role of PSGL-1 in regulating CHO-PSGL-1 cell rolling on human L- or P-selectin was assessed under hydrodynamic flow conditions. Human PSGL-1 expressing cells were less recruited on human P-selectin than CHO cells expressing bovine PSGL-1. Moreover, on human L-selectin, cell recruitment of CHO cells expressing human PSGL-1 was less efficient than that of cells expressing bovine, pig or rat PSGL-1 (Fig. 4A). Surprisingly, CHO cells expressing equine PSGL-1 did not roll on P-selectin and were weakly recruited on L-selectin.
###end p 31
###begin p 32
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rolling of CHO cells expressing human, bovine, pig, rat or equine PSGL-1 on L- or P-selectin</bold>
###xml 94 98 94 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 504 506 501 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 532 536 529 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 907 909 898 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 919 923 910 914 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 39 45 <span type="species:ncbi:9913">bovine</span>
###xml 47 50 <span type="species:ncbi:9823">pig</span>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
###xml 59 65 <span type="species:ncbi:9796">equine</span>
###xml 188 193 <span type="species:ncbi:9606">human</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 295 299 <span type="species:ncbi:9925">goat</span>
###xml 305 310 <span type="species:ncbi:9606">human</span>
###xml 1029 1034 <span type="species:ncbi:9606">human</span>
Rolling of CHO cells expressing human, bovine, pig, rat or equine PSGL-1 on L- or P-selectin. (A) CHO-PSGL-1 cells were perfused under constant shear stress (1.5 dynes/cm2) on recombinant human P-selectin or at 1.0 dyne/cm2 on human L-selectin/mu chimera adsorbed on a coverslip, precoated with goat anti-human IgM antibody, and bound to the bottom of the flow chamber. Cell recruitment was analyzed by videomicroscopy at 4-5 min of perfusion. Results represent the mean +/- SEM of 3-5 experiments (***, P < 0.001; NR: no rolling). (B) Impact of sulfation on PSGL-1-dependent rolling. Control (black columns) and desulfated CHO cells (white columns) were pretreated with proteinase K. Desulfated cells were cultured for 72 h in MEMalpha medium containing 60 mM sodium chlorate and exposed for 60 min to arylsulfatase. Results are expressed as mean percentage of rolling cells +/- SEM of 3 experiments (***, P < 0.001). (C) Amino acid sequence alignments of mammalian homologues of P- and L-selectin lectin domains. Homologues of human residues [16, 18] interacting with sulfated Tyr-48 or -51 are respectively indicated by asterisks or arrowheads. The percentages of identity between aligned sequences are grey shaded (dark grey: > 80%, grey: > 60% and light grey: > 40%).
###end p 32
###begin p 33
###xml 29 30 29 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 816 818 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1036 1037 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 157 162 <span type="species:ncbi:9606">Human</span>
###xml 164 170 <span type="species:ncbi:9913">bovine</span>
###xml 172 175 <span type="species:ncbi:10116">rat</span>
###xml 180 183 <span type="species:ncbi:9823">pig</span>
###xml 267 273 <span type="species:ncbi:9796">equine</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 466 472 <span type="species:ncbi:9913">bovine</span>
###xml 474 477 <span type="species:ncbi:10116">rat</span>
###xml 479 482 <span type="species:ncbi:9823">pig</span>
###xml 487 493 <span type="species:ncbi:9796">equine</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
###xml 758 764 <span type="species:ncbi:9913">bovine</span>
###xml 766 769 <span type="species:ncbi:10116">rat</span>
###xml 975 980 <span type="species:ncbi:9606">human</span>
###xml 1002 1008 <span type="species:ncbi:9913">bovine</span>
###xml 1010 1013 <span type="species:ncbi:9823">pig</span>
###xml 1015 1018 <span type="species:ncbi:10116">rat</span>
###xml 1022 1028 <span type="species:ncbi:9796">equine</span>
Previous studies showed that N-terminal tyrosine sulfate residues are involved in supporting human PSGL-1-dependent rolling on L- and P-selectin [16,20,45]. Human, bovine, rat and pig PSGL-1 exhibit two or three potential N-terminal tyrosine sulfation sites, whereas equine PSGL-1 contains only one single site (Fig. 1A). The contribution of PSGL-1 sulfation to cell rolling was assessed by comparing recruitment of CHO cells expressing control or desulfated human, bovine, rat, pig and equine PSGL-1 on L- or P-selectin (Fig. 4B). Inhibition of PSGL-1 sulfation strongly reduced L- and P-selectin-dependent rolling. The recruitment of CHO cells expressing human PSGL-1, on P-selectin, was inhibited by 88 +/- 5%, whereas the recruitment of cells expressing bovine, rat and porcine PSGL-1 was almost abrogated (Fig. 4B). Rolling inhibition induced by desulfation was also seen on L-selectin (although to a lesser degree than on P-selectin). Thus, as previously described for human PSGL-1, sulfation of bovine, pig, rat or equine PSGL-1 N-terminal tyrosine residues is required to support PSGL-1-dependent rolling on L- or P-selectin.
###end p 33
###begin p 34
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 934 936 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 300 305 <span type="species:ncbi:9606">human</span>
###xml 452 465 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 588 591 <span type="species:ncbi:9823">pig</span>
###xml 596 601 <span type="species:ncbi:9796">horse</span>
###xml 626 631 <span type="species:ncbi:9606">human</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 800 805 <span type="species:ncbi:10090">mouse</span>
###xml 807 817 <span type="species:ncbi:9395">tree shrew</span>
###xml 822 825 <span type="species:ncbi:9685">cat</span>
###xml 873 878 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
###xml 1162 1168 <span type="species:ncbi:9796">equine</span>
###xml 1197 1202 <span type="species:ncbi:9606">human</span>
###xml 1274 1280 <span type="species:ncbi:9796">equine</span>
Interestingly, multiple sequence alignment of mammalian L- or P-selectin shows partial or complete conservation of amino acid residues that regulate human selectin binding to PSGL-1 tyrosine sulfate residues [16,18]. Ser-47, Lys-112 and His-114 on human P-selectin bind to human PSGL-1 Tyr-48, while human L-selectin Lys-85 and P-selectin Arg-85 interact with Tyr-51 (Fig. 4C) [16,18]. In mammalian P-selectins, Ser-47 is conserved, except for bat and rhesus monkey, and Lys-112 and His-114 is either conserved or replaced by arginine, which may interact with sulfated Tyr-48. Except for pig and horse, Arg-85, which binds to human PSGL-1 Tyr-51, is conserved or replaced by lysine (Fig. 4C). L-selectin Ser-47, which binds to human PSGL-1 Tyr-48, is conserved or replaced by a threonine, except for mouse, tree shrew and cat, while L-selectin Lys-85, which interacts with human PSGL-1 Tyr-51, is perfectly conserved. Results of Fig. 4B and alignment of Fig. 4C suggest that, like in human PSGL-1, tyrosine sulfation of mammalian homologues is critical for L- and P-selectin interactions. Sulfation of a unique tyrosine sulfate residue was sufficient to support equine PSGL-1-dependent rolling on human L-selectin (Fig. 4B). However, the recruitment of CHO cells expressing equine PSGL-1 on L-selectin was much less efficient than that of all other CHO cell transfectants (Fig. 4A).
###end p 34
###begin title 35
###xml 36 41 <span type="species:ncbi:9606">human</span>
Mammalian neutrophil recruitment on human L- or P-selectin is heterogeneous
###end title 35
###begin p 36
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 374 376 374 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 683 685 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 850 851 850 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1317 1318 1317 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1554 1555 1554 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1720 1722 1720 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1767 1768 1767 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 216 222 <span type="species:ncbi:9913">bovine</span>
###xml 233 236 <span type="species:ncbi:10116">rat</span>
###xml 241 247 <span type="species:ncbi:9796">equine</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 422 428 <span type="species:ncbi:9913">bovine</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
###xml 517 523 <span type="species:ncbi:9913">bovine</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
###xml 594 599 <span type="species:ncbi:9606">Human</span>
###xml 604 610 <span type="species:ncbi:9913">bovine</span>
###xml 725 728 <span type="species:ncbi:10116">rat</span>
###xml 733 739 <span type="species:ncbi:9796">equine</span>
###xml 797 802 <span type="species:ncbi:9606">human</span>
###xml 806 812 <span type="species:ncbi:9913">bovine</span>
###xml 877 880 <span type="species:ncbi:10116">rat</span>
###xml 885 891 <span type="species:ncbi:9796">equine</span>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
###xml 1071 1077 <span type="species:ncbi:9796">equine</span>
###xml 1086 1092 <span type="species:ncbi:9796">equine</span>
###xml 1156 1159 <span type="species:ncbi:10116">rat</span>
###xml 1189 1194 <span type="species:ncbi:9606">human</span>
###xml 1265 1270 <span type="species:ncbi:9606">human</span>
###xml 1345 1351 <span type="species:ncbi:9913">bovine</span>
###xml 1394 1399 <span type="species:ncbi:9606">human</span>
###xml 1457 1462 <span type="species:ncbi:9606">human</span>
###xml 1526 1529 <span type="species:ncbi:10116">rat</span>
###xml 1534 1540 <span type="species:ncbi:9796">equine</span>
###xml 1634 1637 <span type="species:ncbi:9823">pig</span>
###xml 1641 1644 <span type="species:ncbi:10116">rat</span>
###xml 1698 1703 <span type="species:ncbi:9606">human</span>
The impact of PSGL-1 glycosylation by mammalian FucT-VII and C2GnT-I on PSGL-1-dependent rolling on human L- or P-selectin was assessed under various shear stresses (0.5 to 2.0 dynes/cm2; Fig. 5). The recruitment of bovine, porcine, rat and equine neutrophils on human L- or P-selectin strongly differed from that of the corresponding CHO-PSGL-1 cells (Kruskal-Wallis test, P < 0.0001; Fig. 4A). At 1.5 and 2.0 dynes/cm2, bovine and human neutrophils rolled similarly on P-selectin. However, at lower shear stresses, bovine neutrophils were significantly less recruited than human neutrophils. Human and bovine neutrophil recruitment on L-selectin was similar at 1.0 and 2.0 dynes/cm2 (Fig. 5). Above 0.5 dynes/cm2, porcine, rat and equine neutrophils were less recruited on L- or P-selectin than human or bovine neutrophils (Fig. 5). At 1.5 dynes/cm2, recruitment of porcine, rat and equine neutrophils was respectively 4-, 290- and 3-fold lower on L-selectin and 53- and 36-fold lower on P-selectin than that of human neutrophils. As observed with CHO cells expressing equine PSGL-1, equine neutrophils did not roll on P-selectin. At all shear stresses, rat neutrophils poorly rolled on human L- or P-selectin. These observations are in agreement with results of human selectin chimera binding to neutrophils (Fig. 3); both assays showed that bovine neutrophil PSGL-1 strongly interacts with human L- or P-selectin whereas interactions are weaker between human selectins and porcine neutrophil PSGL-1 and almost absent with rat and equine PSGL-1 (Fig. 5). These results are in contrast with those obtained with CHO cells expressing pig or rat PSGL-1, which are much more efficiently recruited on human selectins (Fig. 4A). Interspecies differences in PSGL-1 core-2 O-glycosylation may explain these observations.
###end p 36
###begin p 37
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L- and P-selectin-dependent recruitment of neutrophils is species-dependent</bold>
###xml 164 166 164 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 481 483 477 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 496 498 492 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 77 82 <span type="species:ncbi:9606">Human</span>
###xml 84 90 <span type="species:ncbi:9913">bovine</span>
###xml 101 104 <span type="species:ncbi:10116">rat</span>
###xml 109 115 <span type="species:ncbi:9796">equine</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 261 265 <span type="species:ncbi:9925">goat</span>
###xml 271 276 <span type="species:ncbi:9606">human</span>
L- and P-selectin-dependent recruitment of neutrophils is species-dependent. Human, bovine, porcine, rat and equine neutrophils were perfused under 0.5-2.0 dynes/cm2 on human P-selectin/mu or on human L-selectin/mu chimera adsorbed on coverslips precoated with goat anti-human IgM antibody. PSGL-1-dependent neutrophil rolling was abolished in presence of 10 mM EDTA. Cell recruitment was assessed at 4-5 min of perfusion. Results represent the mean +/- SEM of 3-4 experiments (*, P < 0.05, ***, P < 0.001).
###end p 37
###begin title 38
###xml 79 84 <span type="species:ncbi:9606">human</span>
Rolling velocities of CHO-PSGL-1 transfectants and of mammalian neutrophils on human L- or P-selectin
###end title 38
###begin p 39
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 210 212 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 710 712 706 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 725 727 720 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 781 783 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 952 954 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 956 958 951 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1161 1162 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 66 72 <span type="species:ncbi:9913">bovine</span>
###xml 74 77 <span type="species:ncbi:9823">pig</span>
###xml 79 82 <span type="species:ncbi:10116">rat</span>
###xml 86 92 <span type="species:ncbi:9796">equine</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 458 461 <span type="species:ncbi:10116">rat</span>
###xml 524 530 <span type="species:ncbi:9796">equine</span>
###xml 601 607 <span type="species:ncbi:9913">bovine</span>
###xml 691 696 <span type="species:ncbi:9606">human</span>
###xml 829 832 <span type="species:ncbi:9823">pig</span>
###xml 836 839 <span type="species:ncbi:10116">rat</span>
###xml 907 912 <span type="species:ncbi:9606">human</span>
###xml 1001 1006 <span type="species:ncbi:9606">human</span>
###xml 1060 1066 <span type="species:ncbi:9913">bovine</span>
###xml 1139 1144 <span type="species:ncbi:9606">human</span>
Rolling velocities of CHO cells and neutrophils expressing human, bovine, pig, rat or equine PSGL-1 were measured under constant shear stress (Fig. 6). Velocities significantly differed among species (Fig. 6A, P < 0.001). CHO cells expressing human PSGL-1 rolled on P- or L-selectin with the slowest velocities (median rolling velocity (mrv) on P-selectin: 3.6 mum/s; on L-selectin: 24.1 mum/s, n = 3). The fastest mrv were exhibited by CHO cells expressing rat PSGL-1 on P-selectin (36.9 mum/s) and by CHO cells expressing equine PSGL-1 cells on L-selectin (121.5 mum/s). Mrv of CHO cells expressing bovine PSGL-1 on P-selectin appeared three times faster than that of CHO cells expressing human PSGL-1 (11.9 vs. 3.6 mum/s, P < 0.001), while they were similar on L-selectin (Fig. 6A). Rolling velocities of CHO cells expressing pig or rat PSGL-1 were significantly higher than that of CHO cells expressing human PSGL-1 on both L- and P-selectin (Fig. 6A, P < 0.001). Compared to CHO cells expressing human PSGL-1, increased velocities of CHO cells expressing bovine PSGL-1 on P-selectin may have resulted in increased cell recruitment on human selectins (Fig. 4).
###end p 39
###begin p 40
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rolling velocities of CHO-PSGL-1 transfectants or neutrophils on human L- or P-selectin</bold>
###xml 89 93 89 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 158 162 158 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 263 264 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 303 304 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 389 393 388 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 410 414 409 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 121 127 <span type="species:ncbi:9913">bovine</span>
###xml 129 132 <span type="species:ncbi:9823">pig</span>
###xml 134 137 <span type="species:ncbi:10116">rat</span>
###xml 141 147 <span type="species:ncbi:9796">equine</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
Rolling velocities of CHO-PSGL-1 transfectants or neutrophils on human L- or P-selectin. (A) CHO cells expressing human, bovine, pig, rat or equine PSGL-1 or (B) neutrophils were perfused under a constant shear stress on recombinant human P-selectin (1.5 dynes/cm2) or L-selectin/mu chimera (1.0 dyne/cm2). Cell velocities were measured at 4-5 min of perfusion. Curves were constructed in (A) using 183-755 or (B) 25-381 independent determinations of cell-rolling velocities and are representative of three experiments. Median rolling velocities, representative of 3 experiments, are indicated.
###end p 40
###begin p 41
###xml 120 122 119 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 147 149 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 254 256 251 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 277 279 273 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 292 294 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 417 419 412 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 440 442 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 586 588 579 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 602 604 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 36 42 <span type="species:ncbi:9913">bovine</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 223 229 <span type="species:ncbi:9913">bovine</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
###xml 483 489 <span type="species:ncbi:9796">equine</span>
The rolling velocities of human and bovine neutrophils on human P-selectin did not differ significantly (mrv: 4.2 mum/s vs. 4.1 mum/s, n = 3, Fig. 6B, left panel), whereas human neutrophils rolled slower on L-selectin than bovine neutrophils (57.2 mum/s vs. 67.1 mum/s, n = 3, P < 0.01, Fig. 6B, right panel). Surprisingly, porcine neutrophils rolled with the fastest velocities on human P-selectin (mrv: 25.3 mum/s, P < 0.001, n = 3; Fig. 6B, left panel), whereas they rolled, like equine neutrophils, with the slowest velocities on L-selectin (46.8 mum/s and 48.9 mum/s, respectively P < 0.001, Fig. 6B, right panel).
###end p 41
###begin p 42
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 671 673 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 785 787 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 896 898 880 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 933 935 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1184 1186 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 395 401 <span type="species:ncbi:9913">bovine</span>
###xml 469 475 <span type="species:ncbi:9913">bovine</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 616 619 <span type="species:ncbi:10116">rat</span>
###xml 790 795 <span type="species:ncbi:9606">Human</span>
###xml 800 806 <span type="species:ncbi:9796">equine</span>
###xml 946 949 <span type="species:ncbi:10116">rat</span>
###xml 1025 1028 <span type="species:ncbi:9823">pig</span>
###xml 1189 1195 <span type="species:ncbi:9913">Bovine</span>
###xml 1200 1206 <span type="species:ncbi:9796">equine</span>
###xml 1368 1374 <span type="species:ncbi:9796">equine</span>
###xml 1454 1460 <span type="species:ncbi:9796">equine</span>
###xml 1516 1522 <span type="species:ncbi:9796">equine</span>
The stability of rolling velocities was assessed by measuring CHO-PSGL-1 cell and neutrophil displacements on human L-selectin within successive video frames (0.1 ms). Peaks represent increases in velocity and valleys decreases (Fig. 7). The stability of CHO-PSGL-1 cell rolling velocities on human L-selectin was heterogeneous among the studied species. Although CHO cells expressing human and bovine PSGL-1 had similar mrv, rolling velocities of CHO cells expressing bovine PSGL-1 (mean SD +/- SD: 21 +/- 3 mum/s) were less stable than those of cells expressing human PSGL-1 (11 +/- 2 mum/s). CHO cells expressing rat PSGL-1 were the least stable (48 +/- 9 mum/s, Fig. 7A). The stability of neutrophil rolling velocities was also highly heterogeneous among the studied species (Fig. 7B). Human and equine neutrophils exhibited the most stable rolling velocities (mean SD +/- SD: 33 +/- 4 mum/s vs. 32 +/- 6 mum/s, n = 10, NS, Fig. 7B), whereas rat neutrophils were the least stable (67 +/- 40 mum/s, n = 4). Interestingly, pig neutrophils exhibited periods of very slow rolling (mean velocity < 10 mum/s) alternating with sudden acceleration, rapidly followed by deceleration (Fig. 7B). Bovine and equine neutrophils had similar behaviors. Despite the presence of oligosaccharides recognized by HECA-452 and CSLEX-1 mAbs on both CHO cells and neutrophils expressing equine PSGL-1, transfected CHO cells rolled significantly faster and less stably than equine neutrophils, suggesting that other structures regulate equine neutrophil rolling.
###end p 42
###begin p 43
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stability of rolling velocities of CHO-PSGL-1 transfectants or mammalian neutrophils on human L-selectin</bold>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 186 192 <span type="species:ncbi:9913">bovine</span>
###xml 194 197 <span type="species:ncbi:9823">pig</span>
###xml 199 202 <span type="species:ncbi:10116">rat</span>
###xml 206 212 <span type="species:ncbi:9796">equine</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
Stability of rolling velocities of CHO-PSGL-1 transfectants or mammalian neutrophils on human L-selectin. Frame-by-frame rolling velocities of (A) CHO-PSGL-1 transfectants or (B) human, bovine, pig, rat or equine neutrophils on human L-selectin. The velocity of tracked cells was determined by measuring cell displacements within successive video frames (0.1 ms) in the flow direction under a shear stress of 1.0 dyne/cm2. Cells were tracked for 4 to 6 s. Data are representative of 4-10 experiments.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;B</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 922 923 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1512 1514 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1670 1671 1670 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 1028 1033 <span type="species:ncbi:9796">horse</span>
###xml 1038 1041 <span type="species:ncbi:9615">dog</span>
###xml 1482 1487 <span type="species:ncbi:9606">human</span>
###xml 1759 1764 <span type="species:ncbi:9606">human</span>
Selectins and PSGL-1 play a critical role in regulating leukocyte migration in inflammatory lesions [4]. Whether human selectins can bind to mammalian PSGL-1 had not been previously studied. As PSGL-1 is an attractive target for anti-inflammatory therapy [29-33,35,37-39], the identification of conserved PSGL-1 functional regions may be helpful to design selectin inhibitors mimicking PSGL-1. We therefore analyzed PSGL-1 amino acid sequences of several mammals (5 previously described sequences; [9,24-26] as well as 9 new sequences described herein, 7 complete and 2 N-terminal sequences; Fig. 1A-B) identified by us or others [25,26]. Multiple sequence alignments (Fig. 1) show that conservation of sequence is not homogeneous along the protein, and that the primary sequence of the site of interaction of L- or P-selectin [16,18] is not perfectly conserved. All sequences contain a threonine homologous to the core-2 O-glycosylated Thr-57 in human, and a T [D/E]PP [D/E] motif, which is conserved in all species, except in horse and dog. Nevertheless, even if the region preceding this threonine always contains at least one tyrosine residue in an anionic environment (predicting sulfation; [57] its length in the mature protein, as well as the number (1 to 3) and positions of the potentially sulfated tyrosine residues are variable. Desulfation and sulfation inhibition studies suggest that tyrosine sulfation plays a key role in supporting mammalian PSGL-1 interaction with human L- and P-selectin (Fig. 4B). Data presented here indicate that L- and P-selectin binding sites on PSGL-1 are evolutionary conserved and emphasize the role of threonine-linked core-2 O-glycans and tyrosine sulfate residues in supporting mammalian PSGL-1 interactions with human selectins.
###end p 45
###begin p 46
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 717 718 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 751 752 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 107 112 <span type="species:ncbi:9796">horse</span>
###xml 281 286 <span type="species:ncbi:9796">horse</span>
###xml 293 299 <span type="species:ncbi:9913">bovine</span>
###xml 301 304 <span type="species:ncbi:9685">cat</span>
###xml 309 314 <span type="species:ncbi:9940">sheep</span>
###xml 441 444 <span type="species:ncbi:10116">rat</span>
###xml 657 663 <span type="species:ncbi:9913">bovine</span>
###xml 670 675 <span type="species:ncbi:9796">horse</span>
###xml 677 680 <span type="species:ncbi:9685">cat</span>
###xml 682 687 <span type="species:ncbi:9940">sheep</span>
###xml 824 827 <span type="species:ncbi:9685">cat</span>
###xml 832 837 <span type="species:ncbi:9940">sheep</span>
A signal peptide is predicted to be cleaved in all PSGL-1 sequences between positions 17 and 18, except in horse where cleavage is predicted between Leu-18 and Gln-19. Nine out of fourteen sequences exhibit a propeptide sequence ended by a PACE cleavage site, whereas five others (horse, bat, bovine, cat and sheep) do not contain it. Of note, the cleavage predictions of both the signal peptide and the propeptide have been corroborated in rat by N-terminal sequencing of PSGL-1.[25] Cleavage predictions suggest that the mature PSGL-1 protein starts at position 42 of the precursor in most studied species, but at position 18 or 19 in five other species (bovine, bat, horse, cat, sheep), and that the length of the N-terminal sequence preceding the O-glycosylated threonine varies from 14 amino acids in bushbaby to 39 in cat and sheep.
###end p 46
###begin p 47
###xml 369 370 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 189 195 <span type="species:ncbi:9913">bovine</span>
###xml 200 206 <span type="species:ncbi:9796">equine</span>
PACE cleaves PSGL-1 propeptide on human neutrophils. In contrast, the propeptide remains on CHO-PSGL-1 cells, which do not express the PACE protease. The lack of PSGL-1 cleavage by PACE in bovine and equine neutrophils did not prevent PSGL-1 interactions with selectins. The importance of propeptide cleavage is unclear: whether it may facilitate tyrosine sulfation or N-terminal O-glycosylation remains to be determined [21].
###end p 47
###begin p 48
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 153 156 <span type="species:ncbi:9615">dog</span>
###xml 161 166 <span type="species:ncbi:9796">horse</span>
###xml 258 264 <span type="species:ncbi:9796">equine</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 335 341 <span type="species:ncbi:9796">equine</span>
###xml 379 385 <span type="species:ncbi:9796">equine</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
###xml 550 555 <span type="species:ncbi:9606">human</span>
The T [D/E]PP [D/E] sequence, which is associated on human and mouse PSGL-1 with threonine O-glycosylation [9,18,58], is observed in most mammals except dog and horse, in which it is respectively replaced by TDAPE and TDLLK sequences. Despite these changes, equine neutrophils rolled on human L-selectin (Fig. 5). By contrast, neither equine neutrophils nor CHO cells expressing equine PSGL-1 significantly interacted with human P-selectin (Fig. 4, 5). This suggests that the T [D/E]PP [D/E] motif may be important for mammalian leukocyte rolling on human P-selectin.
###end p 48
###begin p 49
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 710 713 <span type="species:ncbi:9823">pig</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 885 891 <span type="species:ncbi:9913">bovine</span>
###xml 893 896 <span type="species:ncbi:9823">pig</span>
###xml 900 903 <span type="species:ncbi:10116">rat</span>
We observed that the sequence AATEAQTTQP is the best permutation motif to optimize the number of decameric units per sequence and that the most similar units lie at the center of the mucin-like region, while unconserved amino acids are more frequently present at both ends. This suggests that decamera located at the center of the mucin-like domain might be the most recent and that the evolution of this region might have proceeded by duplications of decameric units, followed by mutations and deletions. This process allowed the conservation of the length of the mucin-like domain with a 250-280 amino acid length (except in bushbaby), despite a variable number of repeated units among species (from 7 DR in pig to 18 DR in monkeys, Table 2). The preservation of PSGL-1 length may play a role in supporting the rolling on human selectins of leukocytes or CHO cells expressing human, bovine, pig or rat PSGL-1 (Fig. 4).
###end p 49
###begin p 50
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 474 476 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 489 491 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 502 504 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 505 507 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 786 792 772 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-fos </italic>
###xml 793 795 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 796 798 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 898 900 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1019 1021 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1139 1141 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 649 654 <span type="species:ncbi:9606">Human</span>
###xml 1125 1130 <span type="species:ncbi:9606">human</span>
Transmembrane and cytoplasmic domain sequences are well conserved (Fig. 1). The juxta-membranous cysteine residue, involved in human PSGL-1 dimerization and in stabilizing leukocyte rolling on P-selectin [27,28,59] is perfectly conserved. A role for PSGL-1 as signaling molecule was indicated by its involvement in activating GTPase Ras and mitogen-activated protein kinases, as well as in inducing the secretion of inflammatory molecules [60-62] or in activating alphaMbeta2 or alphaLbeta2 integrins [63-65]. The high degree of conservation of the cytoplasmic domain suggests that PSGL-1-mediated intracellular signaling is evolutionary conserved. Human PSGL-1 engagement induces Syk phosphorylation and recruitment in lipid rafts as well as the expression of the early-immediate gene c-fos [54,66]. Syk activity, which is critically involved in regulating PSGL-1-dependent rolling on P-selectin [66], is dependent on the binding of PSGL-1 cytoplasmic domain to moesin, which serves as adaptor between PSGL-1 and Syk [54]. Importantly, the moesin binding residues, corresponding to Ser-346, Arg-347, Lys-348, and Ser-358 in human PSGL-1 [54] are perfectly conserved in all analyzed mammalian sequences. Of note, these amino acids are located within a group of 31 amino acids, among which 20 are identical and 5 similar.
###end p 50
###begin p 51
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1035 1037 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1369 1370 1369 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1537 1538 1537 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 65 71 <span type="species:ncbi:9913">bovine</span>
###xml 77 80 <span type="species:ncbi:9823">pig</span>
###xml 162 165 <span type="species:ncbi:10116">rat</span>
###xml 169 175 <span type="species:ncbi:9796">equine</span>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 335 341 <span type="species:ncbi:9913">bovine</span>
###xml 343 346 <span type="species:ncbi:9823">pig</span>
###xml 350 353 <span type="species:ncbi:10116">rat</span>
###xml 505 510 <span type="species:ncbi:9606">human</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
###xml 853 858 <span type="species:ncbi:9606">human</span>
###xml 1199 1204 <span type="species:ncbi:10090">mouse</span>
###xml 1331 1336 <span type="species:ncbi:10090">mouse</span>
###xml 1408 1413 <span type="species:ncbi:9606">human</span>
###xml 1505 1515 <span type="species:ncbi:9395">tree shrew</span>
###xml 1525 1530 <span type="species:ncbi:9796">horse</span>
On L-selectin, rolling velocities of CHO cells expressing human, bovine, and pig PSGL-1 were similar, whereas the median rolling velocity of CHO cells expressing rat or equine PSGL-1 was 4- and 5-fold higher respectively than that of CHO cells expressing human PSGL-1 (Fig. 6). The increased rolling velocities of CHO cells expressing bovine, pig or rat PSGL-1 on P-selectin may partially explain the preserved cell recruitment on P-selectin (Fig. 4A). As all CHO-PSGL-1 transfectants are glycosylated by human C2GnT-I and FucT-VII, differences in CHO-PSGL-1 cell recruitment and rolling velocities may mainly result from differences in N-terminal amino-acid residues interacting with the lectin domain of human L- or P-selectin. Among these residues, tyrosine sulfate residues may critically regulate PSGL-1 interactions with L- or P-selectin, like in human PSGL-1 [16,18,22,45]. The strong inhibition of CHO-PSGL-1 cell interactions with P- or L-selectin after desulfation and inhibition of sulfation supports this possibility (Fig. 4B). In addition, in most studied mammals, the amino acids regulating selectin interactions with potentially sulfated tyrosine residues are conserved (Fig. 4C). In mouse, Tyr-54 and Thr-58 regulate PSGL-1 interactions with P-selectin.[23] Because only one tyrosine is used, it was suggested that mouse PSGL-1 binding may rely more on O-glycans attached to Thr-58 than does human PSGL-1.[23] This may also occur in other mammals, which exhibit a single tyrosine residue (tree shrew, bat and horse, Fig. 1).
###end p 51
###begin p 52
###xml 38 39 38 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 138 144 <span type="species:ncbi:9913">bovine</span>
###xml 146 149 <span type="species:ncbi:9823">pig</span>
###xml 154 160 <span type="species:ncbi:9796">equine</span>
###xml 263 266 <span type="species:ncbi:9823">pig</span>
###xml 289 295 <span type="species:ncbi:9913">bovine</span>
###xml 300 306 <span type="species:ncbi:9796">equine</span>
###xml 540 545 <span type="species:ncbi:9606">human</span>
Differences in tyrosine sulfation and O-glycosylation may affect the stability of rolling velocities on L-selectin. Thus, the patterns of bovine, pig and equine neutrophil displacements differed from those of CHO cells expressing mammalian PSGL-1. In particular, pig neutrophils, and also bovine and equine neutrophils, exhibited periods of very slow rolling velocity, alternating with rapid accelerations and decelerations (Fig. 7). These observations emphasize the role of post-translational modifications in regulating PSGL-1 binding to human selectins.
###end p 52
###begin title 53
Conclusion
###end title 53
###begin p 54
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
Data presented here indicate that mammalian PSGL-1 share a common primary structure and has evolutionary conserved interactions with L- and P-selectin. As in human, PSGL-1-dependent rolling is regulated by core-2 O-glycosylation of a conserved threonine residue and by tyrosine sulfation. The high degree of conservation of PSGL-1 cytoplasmic domain suggests, as for human PSGL-1, a potential involvement in signal transduction and in regulating cell rolling. These results provide additional insights into the structure and function of PSGL-1 and may be helpful to design PSGL-1 peptidomimetics.
###end p 54
###begin title 55
Methods
###end title 55
###begin title 56
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 28 34 <span type="species:ncbi:9796">equine</span>
Bovine, porcine, murine and equine PSGL-1 and FucT-VII cDNAs
###end title 56
###begin p 57
###xml 57 61 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 353 354 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 355 357 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 388 389 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 95 101 <span type="species:ncbi:9913">Bovine</span>
###xml 103 106 <span type="species:ncbi:9823">pig</span>
###xml 111 114 <span type="species:ncbi:10116">rat</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
RNA was extracted from mammalian lymphocytes using TRIzol(R) (Invitrogen, Basel, Switzerland). Bovine, pig and rat homologues of human PSGL-1 cDNAs were generated from lymphocyte total RNA using GeneRacertrade mark Kit (Invitrogen), according to the manufacturer protocols. Primer design was based on sequence homologies between human and mouse PSGL-1 [9,24]. Primers are listed in Table 1.
###end p 57
###begin p 58
Sequences of primers used for RACE and RT-PCR analysis
###end p 58
###begin p 59
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 67 73 <span type="species:ncbi:9913">bovine</span>
###xml 78 81 <span type="species:ncbi:9823">pig</span>
###xml 86 89 <span type="species:ncbi:10116">rat</span>
###xml 94 100 <span type="species:ncbi:9796">equine</span>
Ta, annealing temperature; GSP, gene specific primer; h, human; b, bovine; p, pig; r, rat; e, equine; FucT-VII, alpha1-3 fucosyltranferase-VII.
###end p 59
###begin p 60
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 322 326 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 528 532 508 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 105 111 <span type="species:ncbi:9913">bovine</span>
###xml 113 116 <span type="species:ncbi:9823">pig</span>
###xml 118 121 <span type="species:ncbi:10116">rat</span>
###xml 126 132 <span type="species:ncbi:9796">equine</span>
Full-length PSGL-1 cDNAs were obtained using primers specific for each species (Table 1): forward human, bovine, pig, rat and equine PSGL-1 contain an AflII restriction site and reverse PSGL-1 primers an AgeI and a ClaI restriction site removing the stop codon. Forty amplification cycles were performed using the Platinum(R) Pfx DNA Polymerase (Invitrogen; 30 s at 94degreesC, 45 s at 54degreesC, 2 min at 72degreesC). PCR products were gel-purified, sequenced, digested with AflII/AgeI and cloned in the pcDNA5/FRT/V5-His-TOPO(R) expression vector containing, C-terminally, 6 x His tag (Invitrogen).
###end p 60
###begin p 61
###xml 176 180 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 274 275 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 60 66 <span type="species:ncbi:9913">bovine</span>
###xml 68 71 <span type="species:ncbi:9823">pig</span>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 81 87 <span type="species:ncbi:9796">equine</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
alpha1-3 fucosyltranferase-VII (FucT-VII) mRNAs from human, bovine, pig, rat and equine neutrophils were amplified using the Superscripttrade mark One-Step RT-PCR with platinum(R) Taq Kit (Invitrogen). Primers were derived from human and mammalian FucT-VII sequences (Table 1). beta-actin transcripts were used as control.
###end p 61
###begin title 62
Cells
###end title 62
###begin p 63
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 258 259 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 315 317 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 349 352 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 708 709 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x</sup>
###xml 918 920 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 402 408 <span type="species:ncbi:9913">bovine</span>
###xml 410 413 <span type="species:ncbi:9823">pig</span>
###xml 415 421 <span type="species:ncbi:9796">equine</span>
###xml 425 428 <span type="species:ncbi:10116">rat</span>
###xml 525 529 <span type="species:ncbi:9913">calf</span>
Mammalian lymphocytes were isolated by blood centrifugation on Ficoll and polymorphonuclear cells (PMN) were obtained by dextran sedimentation and erythrocyte hypotonic lysis [10]. Flp-Intrade mark-CHO-K1 cells (Invitrogen) stably expressing core2 beta(1,6)-N-acetyglucosaminyltransferase-I (C2GnT-I) and FucT-VII [16] were transfected using TransIT(R)-LT1 (Mirus Corporation, Madison, WI) with human, bovine, pig, equine or rat PSGL-1 constructs. CHO cells were cultured in MEMalpha medium (Invitrogen) containing 10% fetal calf serum (FCS), 800 mug/mL G418 (Invitrogen) and 700 mug/mL Hygromycin B (Calbiochem-Novabiochem, Schwalbach, Germany). CHO cells co-expressing similar levels of sialyl Lewis x (sLex), cutaneous lymphocyte antigen (CLA) and PSGL-1 terminated by C-terminal polyhistidine (6 x His) tag were isolated by limiting dilution. CHO-P-selectin and 300.19-L-selectin cells were cultured as described [19].
###end p 63
###begin title 64
Inhibition of sulfation
###end title 64
###begin p 65
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 156 158 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 385 387 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 457 478 440 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aerobacter aerogenes </italic>
###xml 457 477 <span type="species:ncbi:548">Aerobacter aerogenes</span>
CHO-PSGL-1 cells (107 cells in 1 mL of PBS) were treated with proteinase K (170 mug/mL; Roche Diagnostics, Rotkreuz, Switzerland) for 20 min at 37degreesC.[67] After proteinase K inhibition with phenylmethylsulphonylfluoride (Sigma-Aldrich, St-Louis, USA), cells were cultured for 72 h in sulfate-deficient MEMalpha medium containing 10% dialyzed FCS and 60 mM sodium chlorate (Sigma [68]). They were then further desulfated, for 60 min at 37degreesC, with Aerobacter aerogenes arylsulfatase (1 U/ml in PBS, type VI, Sigma).
###end p 65
###begin title 66
Immunophenotypic analysis
###end title 66
###begin p 67
###xml 210 212 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Cell staining with mAbs or L-, P-, or E-selectin/IgM heavy chain (mu) chimera was performed and analyzed with a Cytomicstrade mark FC 500 cytofluorimeter (Beckman Instruments, Nyon, Switzerland), as described [19].
###end p 67
###begin title 68
Flow adhesion assays
###end title 68
###begin p 69
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 264 265 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 548 550 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 551 553 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 554 556 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 647 649 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 650 652 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 653 655 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 697 698 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 856 858 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 859 861 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 862 864 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1087 1088 1077 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1157 1159 1147 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1328 1329 1318 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1605 1607 1595 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 1608 1610 1598 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 431 435 <span type="species:ncbi:9925">goat</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
Cells (106/mL) were perfused in a parallel plate flow chamber (GlycoTech Corp., Rockville, MD) mounted on a glass coverslip covered with a confluent monolayer of CHO cells or coated with L-selectin/mu (2.0 mug in 100 muL 0.1 M borate buffer, pH 8.5, surface: 75 mm2) or P-selectin/mu (0.1 mug in 100 muL borate buffer) chimera or recombinant P-selectin (0.5 mug in 100 muL borate buffer) (R&D Systems, Minneapolis, MN) adsorbed on goat anti-human IgM antibody (2.0 mug in 100 muL 0.1 M borate buffer, pH 8.5; Caltag Laboratories, Burlingame, USA; [16,19,69]. CHO-PSGL-1 cell and neutrophil interactions were recorded for 5 min by videomicroscopy [16,19,69]. Rolling velocities illustrated in Fig. 6 were measured by tracking individual cells every 0.1 s, for 1-20 s, using a digital image analysis system (Mikado software, GPIL SA, Martigny, Switzerland; [16,19,69]. 183-755 independent determinations of cell rolling velocities were measured to analyze the velocities of transfectants and 25-381 determinations for the analysis of neutrophil velocities. Frame-by-frame velocities (Fig. 7) were measured by tracking cells every 0.1 s for 6 s, within 0.28 mm2 microscopic fields. The mean velocity of frame-by-frame tracked cells was included between percentiles 40-60 of the velocity of each cell population illustrated in Fig. 6. L- and P-selectin-dependent rolling was inhibited (>95%) by 10 mM EDTA or LAM1-3 or WAPS12.2 mAbs (data not shown). Mock-transfected CHO cells did not roll on L- or P-selectin. CHO transfectants used in adhesion assays expressed similar levels of cell surface PSGL-1 and sLex [19].
###end p 69
###begin title 70
Sequences
###end title 70
###begin p 71
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 122 128 <span type="species:ncbi:9913">bovine</span>
###xml 130 136 <span type="species:ncbi:9796">equine</span>
###xml 138 141 <span type="species:ncbi:9823">pig</span>
###xml 146 149 <span type="species:ncbi:10116">rat</span>
###xml 304 314 <span type="species:ncbi:9598">chimpanzee</span>
###xml 316 329 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 331 334 <span type="species:ncbi:9615">dog</span>
###xml 341 360 <span type="species:ncbi:37347">northern tree shrew</span>
PSGL-1 amino-acid sequences were either retrieved from the Uniprot database [70], or deduced from our own cDNA sequences (bovine, equine, pig and rat respective accession numbers [EMBL: AM778464, AM778465, AM778466, AM778467]), or inferred from their gene sequences identified through homology searches (chimpanzee, rhesus monkey, dog, bat, northern tree shrew, and bushbaby respective EMBL/Genbank/DDBJ accession numbers: AADA01122192, AANU01210210, AAEX02034222, AAPE01064070, AAPY01200400, and AAQR01577322).
###end p 71
###begin p 72
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">49 </sup>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 81 91 <span type="species:ncbi:9598">chimpanzee</span>
###xml 93 106 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 108 111 <span type="species:ncbi:10116">rat</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 123 129 <span type="species:ncbi:9913">bovine</span>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 227 230 <span type="species:ncbi:10116">rat</span>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
###xml 239 245 <span type="species:ncbi:9913">bovine</span>
###xml 247 250 <span type="species:ncbi:9615">dog</span>
###xml 252 255 <span type="species:ncbi:9823">pig</span>
###xml 257 263 <span type="species:ncbi:9796">equine</span>
###xml 268 273 <span type="species:ncbi:9940">sheep</span>
###xml 374 384 <span type="species:ncbi:9598">chimpanzee</span>
###xml 389 402 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 504 507 <span type="species:ncbi:9615">Dog</span>
###xml 509 512 <span type="species:ncbi:9823">pig</span>
###xml 514 533 <span type="species:ncbi:37347">northern tree shrew</span>
###xml 545 548 <span type="species:ncbi:9685">cat</span>
###xml 571 590 <span type="species:ncbi:37347">northern tree shrew</span>
###xml 595 598 <span type="species:ncbi:9685">cat</span>
Most selectin sequences were retrieved from Uniprot. Accession numbers of human, chimpanzee, rhesus monkey, rat, mouse and bovine L-selectins are P14151, Q95237, Q95198, Q63762, P18337 and P98131, respectively. Those of human, rat, mouse, bovine, dog, pig, equine and sheep P-selectin are P16109, P98106, Q01102, P42201, Q28290, Q29097, Q5J3Q6 and P98109, respectively. The chimpanzee and rhesus monkey P-selectin sequences were retrieved from the Refseq database49 (IDs: XM_001137240 and XM_001094728). Dog, pig, northern tree shrew, bushbaby, cat L-selectins, and bat, northern tree shrew and cat P-selectins were predicted from their DNA sequences (EMBL/Genbank/DDBJ respective accession numbers: AAEX02026138, BW973806, AAPY01338510, AAQR01653637, AANG01023786, AAPE01015496, AAPY01338519, AANG01023773).
###end p 72
###begin title 73
Sequence analysis
###end title 73
###begin p 74
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 151 157 <span type="species:ncbi:13443">Coffee</span>
Multiple alignments were obtained by analyzing local and global similarities between PSGL-1 (Fig. 1) or selectin sequences (Fig. 4) using Clustal-W, T-Coffee and MEME programs [71-73]. Alignment was edited and colored using the Jalview program [74]. Signal peptides, propeptides and transmembrane domains were predicted with the SignalP, ProP, and TMHMM programs [75-77].
###end p 74
###begin title 75
Statistical Analysis
###end title 75
###begin p 76
###xml 267 269 267 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Analysis of variance and the Bonferroni multiple comparison test or the Kruskal-Wallis non-parametric ANOVA test were used to assess statistical significance of differences between groups. The Mann-Whitney test was used to compare the medians of two unpaired groups. P values < 0.05 were considered as significant.
###end p 76
###begin title 77
Abbreviations
###end title 77
###begin p 78
CHO cells - Chinese Hamster Ovary cells;
###end p 78
###begin p 79
DR - Decameric repeats; FucT, fucosyltransferases;
###end p 79
###begin p 80
PACE - Paired basic amino acid converting enzymes;
###end p 80
###begin p 81
PSGL-1 - P-selectin glycoprotein ligand-1;
###end p 81
###begin p 82
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x</sup>
sLex - Sialyl Lewis-x;
###end p 82
###begin p 83
TM - Transmembrane domain;
###end p 83
###begin p 84
mrv - Median rolling velocity.
###end p 84
###begin title 85
Authors' contributions
###end title 85
###begin p 86
OS, BB and FG designed research, analyzed data and wrote the paper. BB and SG performed experiments. FG performed multiple alignment. MS critically reviewed the manuscript and contributed to writing. All authors read and approved the final manuscript
###end p 86
###begin title 87
Acknowledgements
###end title 87
###begin p 88
We would like to thank Dr Marco Burki, Dr Giuseppina Milano and Dr Urs Muester for providing mammalian blood samples, and Dr Angela Ciuffi for critical review of our manuscript. This work was supported by the grant ndegrees3200BO-105593 from the Swiss National Foundation for Scientific Research.
###end p 88
###begin article-title 89
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm
###end article-title 89
###begin article-title 90
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo
###end article-title 90
###begin article-title 91
Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment
###end article-title 91
###begin article-title 92
The role of selectins in inflammation and disease
###end article-title 92
###begin article-title 93
Selectins: lectins that initiate cell adhesion under flow
###end article-title 93
###begin article-title 94
Ligands for L-selectin: homing, inflammation, and beyond
###end article-title 94
###begin article-title 95
Leukocyte rolling is mediated by P-selectin glycoprotein ligand-1
###end article-title 95
###begin article-title 96
Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells
###end article-title 96
###begin article-title 97
Expression cloning of a functional glycoprotein ligand for P-selectin
###end article-title 97
###begin article-title 98
P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin on neutrophils, monocytes and CD34+ hematopoietic progenitor cells
###end article-title 98
###begin article-title 99
Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro
###end article-title 99
###begin article-title 100
P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules
###end article-title 100
###begin article-title 101
P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo
###end article-title 101
###begin article-title 102
CD44 is a physiological E-selectin ligand on neutrophils
###end article-title 102
###begin article-title 103
###xml 43 47 <span type="species:ncbi:10090">mice</span>
P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow
###end article-title 103
###begin article-title 104
Molecular basis of leukocyte rolling on PSGL-1: predominant role of core-2 O-glycans and of tyrosine sulfate residue 51
###end article-title 104
###begin article-title 105
A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding
###end article-title 105
###begin article-title 106
Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1
###end article-title 106
###begin article-title 107
###xml 87 92 <span type="species:ncbi:9606">Human</span>
Regulation of PSGL-1 Interactions with L-selectin, P-selectin, and E-selectin: Role of Human Fucosyltransferase-IV and -VII.
###end article-title 107
###begin article-title 108
Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin
###end article-title 108
###begin article-title 109
Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin
###end article-title 109
###begin article-title 110
Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin
###end article-title 110
###begin article-title 111
###xml 23 29 <span type="species:ncbi:10090">murine</span>
###xml 87 93 <span type="species:ncbi:10090">murine</span>
N-terminal residues in murine P-selectin glycoprotein ligand-1 required for binding to murine P-selectin
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor
###end article-title 112
###begin article-title 113
###xml 30 33 <span type="species:ncbi:10116">rat</span>
Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantation
###end article-title 113
###begin article-title 114
###xml 42 48 <span type="species:ncbi:9913">bovine</span>
Molecular cloning and characterization of bovine P-selectin glycoprotein ligand-1
###end article-title 114
###begin article-title 115
Dimerization of a selectin and its ligand stabilizes cell rolling and enhances tether strength in shear flow
###end article-title 115
###begin article-title 116
Dimerization of P-selectin glycoprotein ligand-1 (PSGL-1) required for optimal recognition of P-selectin
###end article-title 116
###begin article-title 117
P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin
###end article-title 117
###begin article-title 118
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling
###end article-title 118
###begin article-title 119
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice
###end article-title 119
###begin article-title 120
###xml 166 170 <span type="species:ncbi:10090">mice</span>
Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice
###end article-title 120
###begin article-title 121
Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect
###end article-title 121
###begin article-title 122
###xml 77 80 <span type="species:ncbi:10116">rat</span>
The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand
###end article-title 122
###begin article-title 123
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1
###end article-title 123
###begin article-title 124
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion
###end article-title 124
###begin article-title 125
Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model
###end article-title 125
###begin article-title 126
###xml 154 159 <span type="species:ncbi:9823">swine</span>
Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine
###end article-title 126
###begin article-title 127
Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion
###end article-title 127
###begin article-title 128
New Links Between Inflammation and Thrombosis
###end article-title 128
###begin article-title 129
Role of P-selectin and PSGL-1 in coagulation and thrombosis
###end article-title 129
###begin article-title 130
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation
###end article-title 130
###begin article-title 131
Protein processing within the secretory pathway
###end article-title 131
###begin article-title 132
PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus
###end article-title 132
###begin article-title 133
Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin
###end article-title 133
###begin article-title 134
Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues
###end article-title 134
###begin article-title 135
###xml 71 76 <span type="species:ncbi:9606">human</span>
Genomic organization and chromosomal localization of the gene encoding human P-selectin glycoprotein ligand.
###end article-title 135
###begin article-title 136
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region
###end article-title 136
###begin article-title 137
Polymorphisms in the P-selectin (CD62P) and P-selectin glycoprotein ligand-1 (PSGL-1) genes and coronary heart disease
###end article-title 137
###begin article-title 138
Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease
###end article-title 138
###begin article-title 139
###xml 29 39 <span type="species:ncbi:10116">Norway rat</span>
Genome sequence of the Brown Norway rat yields insights into mammalian evolution
###end article-title 139
###begin article-title 140
c-Abl Is Involved in the F-Actin Assembly Triggered by L-Selectin Crosslinking
###end article-title 140
###begin article-title 141
PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation
###end article-title 141
###begin article-title 142
A juxta-membrane amino acid sequence of P-selectin glycoprotein ligand-1 is involved in moesin binding and ezrin/radixin/moesin-directed targeting at the trailing edge of migrating lymphocytes
###end article-title 142
###begin article-title 143
Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies
###end article-title 143
###begin article-title 144
###xml 81 87 <span type="species:ncbi:10090">murine</span>
Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells
###end article-title 144
###begin article-title 145
The PROSITE database
###end article-title 145
###begin article-title 146
Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells
###end article-title 146
###begin article-title 147
Functional analysis of the combined role of the O-linked branching enzyme core 2 beta 1-6-N-glucosaminyltransferase and dimerization of PSGL-1 in rolling on P-selectin
###end article-title 147
###begin article-title 148
###xml 50 55 <span type="species:ncbi:9606">human</span>
Activated platelets signal chemokine synthesis by human monocytes
###end article-title 148
###begin article-title 149
Signaling function of PSGL-1 in neutrophil: tyrosine-phosphorylation-dependent and c-Abl-involved alteration in the F-actin-based cytoskeleton
###end article-title 149
###begin article-title 150
P-selectin induces the expression of tissue factor on monocytes
###end article-title 150
###begin article-title 151
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates beta 2-integrin mediated cell attachment to ICAM-1
###end article-title 151
###begin article-title 152
###xml 196 201 <span type="species:ncbi:9606">Human</span>
P-selectin Binding to P-selectin Glycoprotein Ligand-1 Induces an Intermediate State of {alpha}M{beta}2 Activation and Acts Cooperatively with Extracellular Stimuli to Support Maximal Adhesion of Human Neutrophils
###end article-title 152
###begin article-title 153
Rolling of Th1 Cells via P-Selectin Glycoprotein Ligand-1 Stimulates LFA-1-Mediated Cell Binding to ICAM-1
###end article-title 153
###begin article-title 154
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions
###end article-title 154
###begin article-title 155
The alpha (1,3)-fucosyltransferase Fuc-TIV, but not Fuc-TVII, generates sialyl Lewis X-like epitopes preferentially on glycolipids
###end article-title 155
###begin article-title 156
Chlorate--a potent inhibitor of protein sulfation in intact cells
###end article-title 156
###begin article-title 157
Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides: studies with carboxyl-reduced and sulfated heparin and with Trestatin A sulfate
###end article-title 157
###begin article-title 158
The Universal Protein Resource (UniProt)
###end article-title 158
###begin article-title 159
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 159
###begin article-title 160
###xml 2 8 <span type="species:ncbi:13443">Coffee</span>
T-Coffee: A novel method for fast and accurate multiple sequence alignment
###end article-title 160
###begin article-title 161
Fitting a mixture model by expectation maximization to discover motifs in biopolymers
###end article-title 161
###begin article-title 162
The Jalview Java alignment editor
###end article-title 162
###begin article-title 163
A hidden Markov model for predicting transmembrane helices in protein sequences
###end article-title 163
###begin article-title 164
Improved prediction of signal peptides: SignalP 3.0
###end article-title 164
###begin article-title 165
Prediction of proprotein convertase cleavage sites
###end article-title 165

